Accufy Diagnostics raises $2M in October 2026 SEC filing
- Raised in SEC filings
- $2.2M
- Filings
- 2
- Latest est. round
- Seed
- Incorporated
- 2023
- Industry
- Biotechnology
- Based in
- MD
Accufy Diagnostics, based in Maryland, was incorporated in 2023. The biotechnology company first filed with the SEC in October 2025, reporting its first sale on September 23, 2025. This initial filing was for $200K, an estimated Pre-seed/Seed round.
The company filed again in October 2026, reporting a first sale on October 15, 2026. This filing was for $2M, an estimated Seed round. This represents a tenfold increase in the amount raised compared to its first filing. These are estimated rounds.
The latest filing names Jeffrey Hung as Executive Officer and Director, and Zhixiong Xu as Executive Officer and Director. We do not track Accufy Diagnostics' open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-10-15 | $2M | Seed |
| 2025-09-23 | $200K | Pre-seed/Seed |
Named in the latest filing
- Jeffrey Hung
- Zhixiong Xu
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR